Variant Perception

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged. Valcambi acquisition figure cited at USD-actual ($400M, 2015); promoter-flow USD figures derived at FY24 FX (₹/USD 0.01199); large multi-year SEBI revenue figures translated at ~$0.012 average FX.

Where We Disagree With the Market

The sharpest disagreement is with the bull side, not the bear: Valcambi at its 2015 USD-400M acquisition cost is the wrong denominator for the asset floor. At today's compressed refining-toll economics (~$0.20/oz vs ~$1/oz in 2005-2010) and the only public Valcambi standalone data point (CY23 revenue $65M), the through-cycle earnings power of the Swiss refinery may support an asset value materially lower than the dollar sticker. Two further disagreements compound it: the multi-year promoter zero-selling, zero-pledge record (share count constant at 295.3M since FY2015; promoter stake settled at 54.55% by FY2023) that bulls (and Stan) treat as the strongest soft signal of alignment reads more naturally as hostage coordination with the offshore structure SEBI alleges absorbed ~$111M of promoter-linked flows, not as minority-shareholder alignment; and the FY18-FY21 cash decline reportedly from ~$2.22B to ~$280M (per the historian reconstruction; the screener-extracted balance sheet rolls cash into "Other Assets", so the cash sub-line is reconstructed from MD&A and prior IR decks) — roughly $1.9B that left the balance sheet with no disclosed use, three years before the SEBI investigation window even opens — is the structural break the market is not debating. The SEBI 30-day reply (closes ~03-Jul-2026) is the leading indicator on all three.

---

Variant Perception Scorecard

Variant strength is mid-to-high but capped at 68 because the strongest single disagreement (bull's Valcambi denominator) is destructive to the bull case rather than constructive to a different long thesis. Consensus clarity is low-mid because there is no sell-side coverage, no earnings call since Feb-2019, and no published consensus revenue or EPS — the market view has to be reconstructed from the price (0.17× P/B, capitulation low $0.84 dated 30-Mar-2026, death cross since April 2023) and from the Stan/Bull/Bear synthesis. Evidence strength is high because most variant claims tie back to a specific number in the audited filings or to a specific disclosure in the 03-Jun-2026 SEBI order; the pre-FY21 cash trajectory is inferred from the historian's reconstruction and warrants independent verification. Time to resolution is bimodal: the SEBI reply window (~03-Jul-2026) is the leading indicator for variant view #3; the auditor change decision and a Valcambi standalone P&L are the structural confirmations for views #1 and #2 over the next 6-12 months.

---

Consensus Map

There is no analyst consensus on RAJESHEXPO. The consensus signal has to be inferred from the price tape, the volume distribution pattern, the implicit framing in the bull/bear specialist work, and what management has chosen not to say since February 2019.

The consensus is hardest to read on issues #1, #2, #5, and #6 because there is no sell-side coverage to anchor a target. The cleanest consensus signals are price (issue #4) and the persistent zero-pledge/no-recorded-selling promoter record (issue #3) — both are public and unambiguous. Issues #1 and #2 are inferred from the bull-side specialist framing (Stan verdict). The variant ledger below picks the disagreements where the implied assumption is most fragile to specific evidence already on the record.

---

The Disagreement Ledger

Three ranked disagreements. Each survives the five-test gate: testable consensus, contradicting evidence, material to underwriting, observable signal that resolves, and a specific path to being proven wrong.

Disagreement #1 — wrong denominator. Consensus would say: the 2015 acquisition price is a fair-value proxy for Valcambi as a top-3 Swiss LBMA refiner because LBMA standing has not lapsed and capacity has not changed. Our evidence contradicts that. The 2015 deal price was struck when industry refining toll was roughly 5x the current spread; capitalising today's per-ounce economics at an 8-12x multiple plausibly gives an asset value of $48-144M against the bull's $400M anchor. The cleanest disconfirming signal is a published Valcambi standalone P&L — if treatment-fee revenue × tonnage supports through-cycle earnings power in the $36-60M range, our variant fails; if it supports $6-12M, the bull SOTP collapses inside the current trading range and the discount is not a mispricing at all.

Disagreement #2 — hostage geometry, not alignment. Consensus would say: an unchanging 54.55% promoter stake plus a constant 295.3M share count since FY2015 is the strongest possible soft signal of skin-in-game, especially in a low-coverage microcap. Our evidence contradicts that read. SEBI documents ~$111M of undisclosed promoter-linked flows across the same window during which no shares were sold or pledged — and selling or pledging at any earlier point would plausibly have brought SEBI scrutiny forward by years. On this read the stake is rational to hold not because asset value exceeds market price, but because it is a structural backstop to the offshore book. The cleanest disconfirming signal is the first post-SEBI shareholding pattern (~15-Jul-2026): if the promoter pledges or files a SAST sale disclosure inside the survival window, the hostage frame is confirmed; if the stake stays unchanged AND the SEBI reply formally acknowledges and reclassifies the ~$111M flows as RPT, the consensus skin-in-game read survives.

Disagreement #3 — wrong time horizon. Consensus would say: SEBI's case is the substantive scope of disagreement; whatever happened pre-FY21 is either historical noise or already absorbed into book value. Our evidence contradicts that. The historian reconstructs a cash decline of roughly $1.9B across FY18-FY21 with no disclosed use, the loss of the co-founder MD landed in the same window, the IR-advisor chain was abandoned in the same window, and the dividend suspension began three years before earnings collapse — none of which is covered by SEBI's FY21-FY25 scope. If SEBI vacates the FY21-FY25 case on substance, the FY18-FY21 reconstruction still has not been audited or explained. The cleanest disconfirming signal is whether the BDO fresh forensic audit produces a books-of-account trail back into FY18-FY21 — if it does, and the cash use is documented and benign, the variant fails; if not, the structural break is older and broader than the current debate frames it.

---

Evidence That Changes the Odds

Eight pieces of evidence that move the probability of the variant view materially. Each is sourced to a specific upstream artifact and each has at least one path to being misleading.

---

How This Gets Resolved

Six observable signals. Each names a specific filing, document, audit, or disclosure that will validate or refute one of the three variant views. None is "earnings will tell" or "time will reveal."

---

What Would Make Us Wrong

The most decision-relevant red-team exercise here is on disagreement #1, the Valcambi denominator. Bull's anchor uses the 2015 USD-400M deal price; we argue the asset may be worth a fraction of that today. The variant breaks if Valcambi's standalone P&L, when it surfaces, shows treatment-fee earnings power in the $36-60M range at 80%+ cash conversion. That would imply an asset value of $290-720M at an 8-12x multiple — at or above the bull anchor. Two ways this can happen: (a) Valcambi's customer mix is more central-bank-heavy than industry average and central-bank tolls hold higher; (b) CY24-CY25 tonnage stepped up materially with the gold-price rally and the cash-margin compression is overstated in our anchor. The Swiss commercial register or AR Annexure III is the publication node; both could resolve inside 12 months. If they do and the earnings power is strong, the bull SOTP holds and the variant on the denominator collapses.

Disagreement #2 — promoter hostage geometry — breaks if two things happen together: the SEBI reply formally acknowledges and reclassifies the ~$111M flows as RPT (i.e. the promoter takes the documentary cost of disclosure), AND the post-SEBI shareholding pattern shows zero pledge or sale through 2026. The first reframes the alleged diversion as a disclosure failure rather than a substantive misappropriation; the second is consistent with the stake being rationally held under the new RPT regime. If both happen the consensus skin-in-game read survives and our hostage frame is wrong. The asymmetry is in the asks: the variant requires only one signal to validate (a pledge or sale in the survival window); the consensus requires two signals together to refute. That asymmetry is itself part of the case.

Disagreement #3 — wrong time horizon — breaks if the BDO fresh forensic audit produces a documented and benign reconciliation of the reconstructed FY18-FY21 cash decline. The most plausible benign explanation is that the ~$1.9B was absorbed into REL Singapore gold-lease working capital obligations that were not classified as borrowings on the parent and never disclosed because the parent treats them as off-balance-sheet operating positions. If BDO documents that and it ties out, the structural break is not a hole but an under-disclosed operating-cash deployment. That outcome is possible; it is not the prior of someone reading the AR set, but it is achievable inside the 3-6 month audit window. If it lands, the variant on the time horizon weakens substantially.

The least decision-relevant way to be wrong on all three is to be right on every disagreement and lose on liquidity. ~$144K ADV makes the asset price-discovery channel narrow enough that even a definitive validation of all three variant views could fail to re-rate the equity inside any expressible position window. Being right and being able to be paid for it are different questions here.

The first thing to watch is the quality of the SEBI 30-day reply (filed on or by 03-Jul-2026) — specifically whether it produces a Valcambi standalone treatment-fee schedule, because that single document could collapse disagreements #1 and #3 in either direction in one filing.